Pattern of Statins Use in Catalonia

Completed

• Conditions: Hypercholesteremia

• Registration Number: NCT01477944
• Lead Sponsor: AstraZeneca

Brief Summary

To describe the new statins prescription pattern in Catalonia (getting their first prescription for any statin, or receiving a change in their statin treatment including switching, changing in doses or adding ezetimibe/fibrates) since September 2009.

Detailed Description

Pattern of statins use in Catalonia.

Study Timeline

• Study First Submitted: 2011-11-18
• Study First Submitted QC: 2011-11-22
• Study First Posted: 2011-11-23
• Status Verified: 2012-02
• Study Start: 2012-02
• Primary Completion: 2012-02
• Study Completion: 2012-02
• Last Update Submitted: 2012-02-20
• Last Update Posted: 2012-02-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 180723

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Description of detailed clinical treatment in terms of duration of treatment, doses, drug switches and add-on therapy, in patients with hypercholesterolemia and on treatment with statins from the index date.	From 1st September 2009 to 30th August 2010
Type of prescriber	From 1st September 2009 to 30th August 2010	Number of patient, whom the drug was prescribed by the specified type of prescriber (specialist, general practitioner, etc.)
Date of change from previous statin to new.	From 1st September 2009 to 30th August 2010

Secondary Outcome Measures

Name	Time	Method
Description of demographic data including: Sex, Age, Height (cm), Weight (kg), Smoking habits (packs-years), Alcohol consume habits (units/week), active worker or retired, Pregnancy.	From 1st September 2009 to 30th August 2010
Total cholesterol	From 1st September 2009 to 30th August 2010	Total Cholesterol data was collected till the last laboratory values before the date of change from previous statin to new statin.; That values will be collected for all the patients fulfilling criteria.
Low Density Lipoprotein (LDL) cholesterol concentration	From 1st September 2009 to 30th August 2010	LDL cholesterol data was collected till the last laboratory values before the date of change from previous statin to new statin.
High Density Lipoproteins (HDL) cholesterol concentration	From 1st September 2009 to 30th August 2010	HDL data was collected till the last laboratory values before the date of change from previous statin to new statin.
Triglicerides (TG) concentration	From 1st September 2009 to 30th August 2010	TG data was collected till the last laboratory values before the date of change from previous statin to new statin.
Aspartate Aminotransferase (ASAT) concentration	From 1st September 2009 to 30th August 2010	ASAT data was collected till the last laboratory values before the date of change from previous statin to new statin.
Serum Glucose concentration	From 1st September 2009 to 30th August 2010	Serum Glucose data was collected till the last laboratory values before the date of change from previous statin to new statin.
Serum Creatin Kinase (CK) concentration	From 1st September 2009 to 30th August 2010	CK data was collected till the last laboratory values before the date of change from previous statin to new statin.